+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Superdisintegrants - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141537

Global Superdisintegrants Market to Reach $567.2 Million by 2030

The global market for Superdisintegrants estimated at US$373.4 Million in the year 2022, is projected to reach a revised size of US$567.2 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$262.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Natural Superdisintegrants segment is readjusted to a revised 5.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 9.4% CAGR

The Superdisintegrants market in the U.S. is estimated at US$100.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 46 Featured) -

  • Asahi Kasei Corporation
  • Ashland Global Holdings, Inc.
  • Avantor Performance Materials LLC
  • BASF SE
  • Corel Pharma Chem
  • DFE Pharma GmbH & Co. KG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jrs Pharma GmbH Co. KG
  • Merck KgaA
  • Roquette Freres S.A.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Superdisintegrants - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Natural Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Natural Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Natural Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Synthetic Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Synthetic Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Synthetic Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 28: World Superdisintegrants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: USA Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: USA 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: USA Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: USA 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Canada 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: Canada 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • JAPAN
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: Japan 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Japan 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • CHINA
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: China Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: China 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: China Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: China 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • EUROPE
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Superdisintegrants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: Europe 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: Europe 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: Europe 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • FRANCE
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 62: France Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: France Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: France 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: France Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: France 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • GERMANY
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 68: Germany Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Germany 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: Germany 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: Italy 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: Italy 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 80: UK Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: UK Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: UK 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: UK Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: UK 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • SPAIN
  • Table 86: Spain Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Spain Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Spain 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 89: Spain Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Spain Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Spain 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • RUSSIA
  • Table 92: Russia Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Russia Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Russia 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 95: Russia Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 96: Russia Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 97: Russia 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 100: Rest of Europe 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 101: Rest of Europe Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Rest of Europe Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 103: Rest of Europe 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Superdisintegrants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 109: Asia-Pacific 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2023 & 2030
  • Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 111: Asia-Pacific Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 112: Asia-Pacific 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2023 & 2030
  • AUSTRALIA
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • INDIA
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asahi Kasei Corporation
  • Ashland Global Holdings, Inc.
  • Avantor Performance Materials LLC
  • BASF SE
  • Corel Pharma Chem
  • DFE Pharma GmbH & Co. KG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jrs Pharma GmbH Co. KG
  • Merck KgaA
  • Roquette Freres S.A.

Table Information